TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of the Implementation of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older
Brief Summary: The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older.

This is a cluster-randomized study with a stepped-wedge design. Clusters correspond to participating centers. A randomly selected center is crossed-over into the intervention every fifteen days after the start of inclusions.


Options:
A: Arm Label: Pharmaceutical care program; Type: EXPERIMENTAL; Interventions: Other: Pharmaceutical Care Program | Arm Label: Standard Care; Type: OTHER; Interventions: Other: Standard Care | Intervention Type: OTHER; Name: Pharmaceutical Care Program; Assigned to Arm(s): Pharmaceutical care program | Intervention Type: OTHER; Name: Standard Care; Assigned to Arm(s): Standard Care
B: Arm Label: Before collarborative pharmaceutical care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: After collarborative pharmaceutical care; Type: EXPERIMENTAL; Interventions: Other: Collaborative Pharmaceutical Care | Intervention Type: OTHER; Name: Collaborative Pharmaceutical Care; Assigned to Arm(s): After collarborative pharmaceutical care
C: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease | Intervention Type: BEHAVIORAL; Name: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease; Assigned to Arm(s): 2
D: Arm Label: Unrestricted; Type: ACTIVE_COMPARATOR; Interventions: Other: Unrestricted | Arm Label: Restricted; Type: ACTIVE_COMPARATOR; Interventions: Other: Restricted | Intervention Type: OTHER; Name: Unrestricted; Assigned to Arm(s): Unrestricted | Intervention Type: OTHER; Name: Restricted; Assigned to Arm(s): Restricted

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of the Implementation of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older
Brief Summary: The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older.

This is a cluster-randomized study with a stepped-wedge design. Clusters correspond to participating centers. A randomly selected center is crossed-over into the intervention every fifteen days after the start of inclusions.


Options:
A: Arm Label: Control period; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention period; Type: EXPERIMENTAL; Interventions: Other: Introducing clinical pharmacists to the interdisciplinary ED team. | Intervention Type: OTHER; Name: Introducing clinical pharmacists to the interdisciplinary ED team.; Assigned to Arm(s): Intervention period
B: Arm Label: Before collarborative pharmaceutical care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: After collarborative pharmaceutical care; Type: EXPERIMENTAL; Interventions: Other: Collaborative Pharmaceutical Care | Intervention Type: OTHER; Name: Collaborative Pharmaceutical Care; Assigned to Arm(s): After collarborative pharmaceutical care
C: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Arm 2
D: Arm Label: Intervention; Type: OTHER; Interventions: Other: E-learning | Arm Label: Control; Type: OTHER; Interventions: Other: E-learning | Intervention Type: OTHER; Name: E-learning; Assigned to Arm(s): Control, Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Transobturator Versus Single Incision Slings: 1 Year Results of a Randomized Control Trial
Brief Summary: A randomized control trial to compare the efficacy of the single incision mini-sling to the transobturator sling


Options:
A: Arm Label: Monarc; Type: ACTIVE_COMPARATOR; Interventions: Device: Monarc | Arm Label: Mini-arc; Type: EXPERIMENTAL; Interventions: Device: Mini-arc | Intervention Type: DEVICE; Name: Mini-arc; Assigned to Arm(s): Mini-arc | Intervention Type: DEVICE; Name: Monarc; Assigned to Arm(s): Monarc
B: Arm Label: Mini-sling; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Mini-sling | Arm Label: Transobturator; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Transobturator | Intervention Type: PROCEDURE; Name: Mini-sling; Assigned to Arm(s): Mini-sling | Intervention Type: PROCEDURE; Name: Transobturator; Assigned to Arm(s): Transobturator
C: Arm Label: TVT SECURE; Type: ACTIVE_COMPARATOR; Interventions: Procedure: transvaginal obturator tape | Arm Label: TVT O; Type: ACTIVE_COMPARATOR; Interventions: Procedure: transvaginal obturator tape | Intervention Type: PROCEDURE; Name: transvaginal obturator tape; Assigned to Arm(s): TVT O, TVT SECURE
D: Arm Label: SIS single incision sling; Type: EXPERIMENTAL; Interventions: Device: SIS - Innovative fixation single incision sling | Arm Label: TOT trans obturator tape/sling; Type: ACTIVE_COMPARATOR; Interventions: Device: TOT - inside-out trans-obturator tape/sling | Intervention Type: DEVICE; Name: TOT - inside-out trans-obturator tape/sling; Assigned to Arm(s): TOT trans obturator tape/sling | Intervention Type: DEVICE; Name: SIS - Innovative fixation single incision sling; Assigned to Arm(s): SIS single incision sling

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Fear of Cancer Recurrence (FoR) Trajectory During Radiation Treatment and Follow-up Into Survivorship of 100 Breast Cancer patients-a Pilot Study
Brief Summary: This pilot study concentrates on studying the trajectory of breast cancer patient's fear of recurrence (FoR) over the course of radiation therapy. The aim is to collect repeated ratings of 100 breast cancer patient's FoR over the course of their treatment. It is hypothesized that cancer patient's FoR level will rise on nearing the termination of the in radiotherapy treatment, and radiotherapist-patient interaction modifies the development of patient's FoR.


Options:
A: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Mini-AFTERc | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mini-AFTERc; Assigned to Arm(s): Intervention group
B: Arm Label: breast cancer radiation therapy; Type: N/A; Interventions: N/A
C: Arm Label: Survivorship Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Survivorship Intervention | Arm Label: Facing Forward; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Facing Forward | Intervention Type: BEHAVIORAL; Name: Survivorship Intervention; Assigned to Arm(s): Survivorship Intervention | Intervention Type: BEHAVIORAL; Name: Facing Forward; Assigned to Arm(s): Facing Forward
D: Arm Label: ENABLE (concurrent palliative care); Type: EXPERIMENTAL; Interventions: Other: counseling intervention, Other: educational intervention, Procedure: psychosocial assessment and care, Procedure: quality-of-life assessment | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: counseling intervention, Procedure: psychosocial assessment and care, Procedure: quality-of-life assessment | Intervention Type: OTHER; Name: counseling intervention; Assigned to Arm(s): ENABLE (concurrent palliative care), Usual Care | Intervention Type: OTHER; Name: educational intervention; Assigned to Arm(s): ENABLE (concurrent palliative care) | Intervention Type: PROCEDURE; Name: psychosocial assessment and care; Assigned to Arm(s): ENABLE (concurrent palliative care), Usual Care | Intervention Type: PROCEDURE; Name: quality-of-life assessment; Assigned to Arm(s): ENABLE (concurrent palliative care), Usual Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Short-term Effects of Animal-assisted Therapy on the Rehabilitation Process of Brain-injured Patients at REHAB Basel
Brief Summary: The purpose is to investigate whether animal-assisted therapy has positive biopsychosocial effects on patients with brain injuries. This study investigates the short-term biopsychosocial effects that occur when animals are present during therapy sessions in comparison to therapy sessions without animals, observing a group of 25 patients over 24 therapy sessions. While half of the sessions are held in presence of an animal and half without, they are as comparable as possible with respect to content and setting. In this study, patients who are in a slightly advanced rehabilitation process, assessed via their function profile, are investigated.


Options:
A: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Behavioral: Educational intervention | Arm Label: Application smartphone-based group; Type: EXPERIMENTAL; Interventions: Behavioral: Educational intervention, Device: Smartphone-based application | Arm Label: Non Application smartphone-based group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Educational intervention; Assigned to Arm(s): Application smartphone-based group, Experimental group | Intervention Type: DEVICE; Name: Smartphone-based application; Assigned to Arm(s): Application smartphone-based group
B: Arm Label: Virtual Reality; Type: EXPERIMENTAL; Interventions: Procedure: Virtual Reality | Arm Label: Paper and Pencil; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Paper and Pencil | Arm Label: Conventional Therapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional Therapy | Intervention Type: PROCEDURE; Name: Virtual Reality; Assigned to Arm(s): Virtual Reality | Intervention Type: PROCEDURE; Name: Paper and Pencil; Assigned to Arm(s): Paper and Pencil | Intervention Type: PROCEDURE; Name: Conventional Therapy; Assigned to Arm(s): Conventional Therapy
C: Arm Label: animal assisted therapy; Type: EXPERIMENTAL; Interventions: Other: animal assisted therapy | Arm Label: standard therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: standard therapy | Intervention Type: OTHER; Name: animal assisted therapy; Assigned to Arm(s): animal assisted therapy | Intervention Type: OTHER; Name: standard therapy; Assigned to Arm(s): standard therapy
D: Arm Label: Mentor; Type: EXPERIMENTAL; Interventions: Behavioral: Mentor | Arm Label: Traditional rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mentor | Intervention Type: BEHAVIORAL; Name: Mentor; Assigned to Arm(s): Mentor, Traditional rehabilitation

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: As cancer mortality rates improve in Asia, there is an increasing focus on patient-reported outcomes and survivorship issues. In view of the numerous medication and psychosocial issues that are commonly faced by early-stage breast cancer survivors, it deems important to develop and conduct specific interventional programs to mitigate these problems. In the literature, it is well recognized that psychosocial interventions are effective to manage emotional distress and quality of life, with the evidence clearly clustered in studies on female patients with breast cancer. One meta-analysis suggested that psycho-oncologic interventions including individual psychotherapy, group psychotherapy, psychoeducation, relaxing training can produce positive effects on emotional distress, anxiety and depression, and health-related QOL.

The investigators hypothesize that a significant reduction in anxiety, improvement of cognition and improvement of health-related quality of life among those who receive psycho-education, in comparison to those in the usual care. Hence, this randomized trial is designed to assess the effectiveness of a psycho-educational group (PEG) intervention on supportive care and survivorship issues, which include anxiety, depression, cognitive function, toxicities management of cancer- or treatment- related physical symptoms, and health-related quality of life in early-stage breast cancer patients.


Options:
A: Arm Label: Compassion; Type: EXPERIMENTAL; Interventions: Behavioral: CBCT | Arm Label: Treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Other: TAU | Intervention Type: BEHAVIORAL; Name: CBCT; Assigned to Arm(s): Compassion | Intervention Type: OTHER; Name: TAU; Assigned to Arm(s): Treatment as usual
B: Arm Label: Intervention Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducation group | Arm Label: Usual Care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: Psychoeducation group; Assigned to Arm(s): Intervention Arm | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care
C: Intervention Type: BEHAVIORAL; Name: Group Therapy Intervention; Assigned to Arm(s): N/A
D: Arm Label: Standard Online Support Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Online Support Group | Arm Label: Prosocial Online Support Group; Type: EXPERIMENTAL; Interventions: Behavioral: prosocial online support group | Intervention Type: BEHAVIORAL; Name: prosocial online support group; Assigned to Arm(s): Prosocial Online Support Group | Intervention Type: BEHAVIORAL; Name: Standard Online Support Group; Assigned to Arm(s): Standard Online Support Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis
Brief Summary: Outpatient (phase 2) pulmonary rehab is an important, but mostly underutilized intervention to improve physical function in patients with idiopathic pulmonary fibrosis (IPF). Of those individuals who complete phase 2 pulmonary rehab, only a small cohort continues with any type of maintenance exercise therapy (phase 3). This is largely due to personal factors, such as access to transportation, weather, scheduling difficulties, and cost.

Little is known about how to enhance physical activity among patients with IPF. In addition, no studies have investigated the long-term maintenance strategies of physical training in patients with IPF. Thus, the purpose of this study is to test the feasibility and effectiveness of a home-based, pulmonary rehab program for patients with IPF. A randomized, blinded, clinical trial (RCT) design with two arms -- Wii Fit Plus exergame program and cognitive video gaming, with no active whole body movement involved - will be used to investigate the benefits of a home-based exergame program on improving pulmonary-related function and symptoms in patients with IPF.


Options:
A: Arm Label: Nintedanib; Type: EXPERIMENTAL; Interventions: Drug: Nintedanib | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Nintedanib; Assigned to Arm(s): Nintedanib | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Intervention Type: BEHAVIORAL; Name: Pulmonary Rehabilitation; Assigned to Arm(s): N/A
C: Arm Label: Physical exercise training; Type: EXPERIMENTAL; Interventions: Behavioral: Physical exercise training | Arm Label: Cognitive exercise training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive exercise training | Intervention Type: BEHAVIORAL; Name: Physical exercise training; Assigned to Arm(s): Physical exercise training | Intervention Type: BEHAVIORAL; Name: Cognitive exercise training; Assigned to Arm(s): Cognitive exercise training
D: Arm Label: BIBF 1120; Type: EXPERIMENTAL; Interventions: Drug: BIBF 1120 | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: BIBF 1120; Assigned to Arm(s): BIBF 1120

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis
Brief Summary: Outpatient (phase 2) pulmonary rehab is an important, but mostly underutilized intervention to improve physical function in patients with idiopathic pulmonary fibrosis (IPF). Of those individuals who complete phase 2 pulmonary rehab, only a small cohort continues with any type of maintenance exercise therapy (phase 3). This is largely due to personal factors, such as access to transportation, weather, scheduling difficulties, and cost.

Little is known about how to enhance physical activity among patients with IPF. In addition, no studies have investigated the long-term maintenance strategies of physical training in patients with IPF. Thus, the purpose of this study is to test the feasibility and effectiveness of a home-based, pulmonary rehab program for patients with IPF. A randomized, blinded, clinical trial (RCT) design with two arms -- Wii Fit Plus exergame program and cognitive video gaming, with no active whole body movement involved - will be used to investigate the benefits of a home-based exergame program on improving pulmonary-related function and symptoms in patients with IPF.


Options:
A: Arm Label: Urban training Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Urban training | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Urban training; Assigned to Arm(s): Urban training Intervention
B: Arm Label: Home-based pulmonary rehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based pulmonary rehabilitation | Arm Label: Hospital-based pulmonary rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Hospital-based pulmonary rehabilitation | Intervention Type: BEHAVIORAL; Name: Home-based pulmonary rehabilitation; Assigned to Arm(s): Home-based pulmonary rehabilitation | Intervention Type: BEHAVIORAL; Name: Hospital-based pulmonary rehabilitation; Assigned to Arm(s): Hospital-based pulmonary rehabilitation
C: Arm Label: Physical exercise training; Type: EXPERIMENTAL; Interventions: Behavioral: Physical exercise training | Arm Label: Cognitive exercise training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive exercise training | Intervention Type: BEHAVIORAL; Name: Physical exercise training; Assigned to Arm(s): Physical exercise training | Intervention Type: BEHAVIORAL; Name: Cognitive exercise training; Assigned to Arm(s): Cognitive exercise training
D: Arm Label: HappyAir Group; Type: EXPERIMENTAL; Interventions: Other: Pulmonary Care Web-Based App (HappyAir App) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Pulmonary Care Web-Based App (HappyAir App); Assigned to Arm(s): HappyAir Group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Vaginal Administration of Alpha Lipoic Acid vs Progesterone for the Subchorionic Hematoma Treatment
Brief Summary: The aim of this study was to compare the therapeutic efficacy of lipoic acid versus progesterone by vaginal administration on subchorionic hematoma resorption in women at the first trimester of pregnancy with threatened miscarriage.


Options:
A: Arm Label: Dydrogesterone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dydrogesterone | Arm Label: Placebo pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Dydrogesterone; Assigned to Arm(s): Dydrogesterone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo pill
B: Arm Label: mifepristone+misoprostol; Type: EXPERIMENTAL; Interventions: Drug: mifepristone+misoprostol | Arm Label: misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: misoprostol+placebo | Intervention Type: DRUG; Name: mifepristone+misoprostol; Assigned to Arm(s): mifepristone+misoprostol | Intervention Type: DRUG; Name: misoprostol+placebo; Assigned to Arm(s): misoprostol
C: Arm Label: 17 alfa hydroxy Progesterone caproate; Type: ACTIVE_COMPARATOR; Interventions: Drug: 17 alpha-hydroxy progesterone caproate | Arm Label: Micronized Progesterone; Type: ACTIVE_COMPARATOR; Interventions: Drug: micronized Progesterone | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Control | Intervention Type: DRUG; Name: 17 alpha-hydroxy progesterone caproate; Assigned to Arm(s): 17 alfa hydroxy Progesterone caproate | Intervention Type: DRUG; Name: micronized Progesterone; Assigned to Arm(s): Micronized Progesterone | Intervention Type: PROCEDURE; Name: Control; Assigned to Arm(s): Control
D: Arm Label: Lipoic acid; Type: EXPERIMENTAL; Interventions: Device: Lipoic acid | Arm Label: Progesterone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Progesterone | Intervention Type: DEVICE; Name: Lipoic acid; Assigned to Arm(s): Lipoic acid | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): Progesterone

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Vaginal Administration of Alpha Lipoic Acid vs Progesterone for the Subchorionic Hematoma Treatment
Brief Summary: The aim of this study was to compare the therapeutic efficacy of lipoic acid versus progesterone by vaginal administration on subchorionic hematoma resorption in women at the first trimester of pregnancy with threatened miscarriage.


Options:
A: Arm Label: Oral dydrogesterone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oral dydrogesterone | Arm Label: Crinone 8% vaginal gel; Type: ACTIVE_COMPARATOR; Interventions: Drug: Crinone 8% gel | Intervention Type: DRUG; Name: Oral dydrogesterone; Assigned to Arm(s): Oral dydrogesterone | Intervention Type: DRUG; Name: Crinone 8% gel; Assigned to Arm(s): Crinone 8% vaginal gel
B: Arm Label: Lipoic acid; Type: EXPERIMENTAL; Interventions: Device: Lipoic acid | Arm Label: Progesterone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Progesterone | Intervention Type: DEVICE; Name: Lipoic acid; Assigned to Arm(s): Lipoic acid | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): Progesterone
C: Arm Label: LMWH + Folic acid group; Type: EXPERIMENTAL; Interventions: Drug: LMWH+Folic acid | Arm Label: Folic acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Folic Acid | Intervention Type: DRUG; Name: LMWH+Folic acid; Assigned to Arm(s): LMWH + Folic acid group | Intervention Type: DRUG; Name: Folic Acid; Assigned to Arm(s): Folic acid
D: Arm Label: Vaginal progesterone group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Progesterone | Arm Label: No progesterone group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): Vaginal progesterone group

Answer: B